Oct 11 (Reuters) - Telesta Therapeutics Inc TST.TO :
* Leading independent advisory firms ISS and Glass Lewis recommend shareholders vote for the plan of arrangement Between Telesta Therapeutics Inc and Prometic Life Sciences Inc Source text for Eikon: ID:nCNWztGkRa Further company coverage: TST.TO